Your Shortcut to AACR 2026 Bispecific Insight
From hundreds of presentations, we identified 258 bispecific‑relevant abstracts linked to Beacon records – a 22% increase compared with AACR 2025, highlighting growing research intensity across oncology.
Our analysts have translated this volume into concise, decision‑ready insight, complete with clear summaries and direct links for deeper exploration.
This year’s analysis includes:
- 45 clinical studies, spanning trial outlines and clinical results
- 214 preclinical insights, reinforcing sustained early‑stage innovation
- 98 newly identified bispecific assets, a 32% increase year‑on‑year, underscoring continued pipeline expansion
Whether you’re tracking competitive movement, evaluating pipeline direction, or monitoring emerging biology, this report brings the most important bispecific findings straight to you.
You May Also Be Interested In…
Learn More About Bispecific
- The Most Comprehensive Way to Search the Bispecific Drug Development Landscape: Unique search ontologies based on Bispecific drug and trial characteristics
- Market Leading Approach to Bispecific Preclinical & Clinical Data Curation: Manual curation of key Bispecific research and development data points Bispecific research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Bispecific company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
